The CARA Act
Description
This webinar will provide information on the Comprehensive Addiction and Recovery Act as it affects APNs and PAs who are waivered to prescribe buprenorphine. Additionally, information about the optimal populations who would benefit from buprenorphine maintenance along with suggested protocols for induction, titration and maintenance.
EDUCATIONAL OBJECTIVES
Summarize the elements of the Comprehensive Addiction and Recovery Act. Describe the patient population who will respond best to buprenorphine maintenance. Discuss protocols for induction and maintenance of buprenorphine.
PRESENTERS
William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP, FIAAN
Vice President and Chief Clinical Officer
Livengrin Foundation, Inc.
NURSING CE
This webinar is not eligible for Nursing CE
Have a question? Get in touch with our dedicated support team Contact Us
Contact usPhone Phone calls are managed by Prime Management Services International Nurses Society on Addictions (IntNSA) Office Hours: 8:30 am–5:00 pm CT, Monday–Friday | Our missionTo advance excellence in nursing care for the prevention and treatment of addictions for diverse populations across all practice setting through advocacy, collaboration, education, research and policy development. | Connect with us    
|